Schiffer CA - Search Results

1

BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia.

Schiffer CA. Schiffer CA. N Engl J Med. 2007 Jul 19;357(3):258-65. doi: 10.1056/NEJMct071828. N Engl J Med. 2007. PMID: 17634461 Review. No abstract available.

2

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA. Stone RM, et al. Among authors: schiffer ca. N Engl J Med. 1995 Jun 22;332(25):1671-7. doi: 10.1056/NEJM199506223322503. N Engl J Med. 1995. PMID: 7760868 Free article. Clinical Trial.

3

STI-571: current status and future prospects.

Schiffer CA. Schiffer CA. Curr Opin Investig Drugs. 2001 Sep;2(9):1279-81. Curr Opin Investig Drugs. 2001. PMID: 11717816 Review. No abstract available.

4

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.

Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B, Goldman J, O'Brien SG, Russell N, Fischer T, Ottmann O, Cony-Makhoul P, Facon T, Stone R, Miller C, Tallman M, Brown R, Schuster M, Loughran T, Gratwohl A, Mandelli F, Saglio G, Lazzarino M, Russo D, Baccarani M, Morra E; International STI571 CML Study Group. Kantarjian H, et al. N Engl J Med. 2002 Feb 28;346(9):645-52. doi: 10.1056/NEJMoa011573. N Engl J Med. 2002. PMID: 11870241 Free article. Clinical Trial.

5

The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.

Mohamed AN, Pemberton P, Zonder J, Schiffer CA. Mohamed AN, et al. Among authors: schiffer ca. Clin Cancer Res. 2003 Apr;9(4):1333-7. Clin Cancer Res. 2003. PMID: 12684401 Clinical Trial.

6

The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment.

Zonder JA, Pemberton P, Brandt H, Mohamed AN, Schiffer CA. Zonder JA, et al. Among authors: schiffer ca. Clin Cancer Res. 2003 Jun;9(6):2092-7. Clin Cancer Res. 2003. PMID: 12796373

7

Practical aspects of the treatment of chronic myelogenous leukemia with imatinib mesylate.

Zonder JA, Schiffer CA. Zonder JA, et al. Among authors: schiffer ca. Curr Hematol Rep. 2003 Jan;2(1):57-64. Curr Hematol Rep. 2003. PMID: 12901155 Review.

8

Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia.

Schiffer CA. Schiffer CA. N Engl J Med. 2003 Aug 21;349(8):727-9. doi: 10.1056/NEJMp030076. N Engl J Med. 2003. PMID: 12930923 No abstract available.

9

"Acute myelogenous leukemia like" translocations in CML blast crisis: two new cases of inv(16)/t(16;16) and a review of the literature.

Patel BB, Mohamed AN, Schiffer CA. Patel BB, et al. Among authors: schiffer ca. Leuk Res. 2006 Feb;30(2):225-32. doi: 10.1016/j.leukres.2005.06.008. Epub 2005 Aug 1. Leuk Res. 2006. PMID: 16076492 Review.

10

Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.

Kantarjian H, Schiffer C, Jones D, Cortes J. Kantarjian H, et al. Blood. 2008 Feb 15;111(4):1774-80. doi: 10.1182/blood-2007-09-110189. Epub 2007 Nov 30. Blood. 2008. PMID: 18055868 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

546 results

Search Page